| Literature DB >> 26487785 |
Michael Traurig1, Robert L Hanson1, Alejandra Marinelarena1, Sayuko Kobes1, Paolo Piaggi1, Shelley Cole2, Joanne E Curran3, John Blangero3, Harald Göring3, Satish Kumar3, Robert G Nelson1, Barbara V Howard4, William C Knowler1, Leslie J Baier1, Clifton Bogardus5.
Abstract
Genetic variants in SLC16A11 were recently reported to be associated with type 2 diabetes in Mexican and other Latin American populations. The diabetes risk haplotype had a frequency of 50% in Native Americans from Mexico but was rare in Europeans and Africans. In the current study, we analyzed SLC16A11 in 12,811 North American Indians and found that the diabetes risk haplotype, tagged by the rs75493593 A allele, was nominally associated with type 2 diabetes (P = 0.001, odds ratio 1.11). However, there was a strong interaction with BMI (P = 5.1 × 10(-7)) such that the diabetes association was stronger in leaner individuals. rs75493593 was also strongly associated with BMI in individuals with type 2 diabetes (P = 3.4 × 10(-15)) but not in individuals without diabetes (P = 0.77). Longitudinal analyses suggest that this is due, in part, to an association of the A allele with greater weight loss following diabetes onset (P = 0.02). Analyses of global gene expression data from adipose tissue, skeletal muscle, and whole blood provide evidence that rs75493593 is associated with expression of the nearby RNASEK gene, suggesting that RNASEK expression may mediate the effect of genotype on diabetes.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26487785 PMCID: PMC4747458 DOI: 10.2337/db15-0571
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461